Oligodendrocyte progenitor cell
Oligodendrocyte progenitor cell | |
---|---|
Details | |
System | Central nervous system |
Location | Brain, Spinal cord |
Identifiers | |
Acronym(s) | OPC |
MeSH | D000073637 |
TH | H2.00.06.2.01007 |
Anatomical terms of microanatomy |
Oligodendrocyte progenitor cells (OPCs), also known as oligodendrocyte precursor cells, NG2-glia, O2A cells, or polydendrocytes, are a subtype of
OPCs play a critical role in developmental and adult
Structure
OPCs are
OPCs are present throughout the brain, including the hippocampus and in all layers of the neocortex.[7] They distribute themselves and achieve a relatively even distribution through active self-repulsion.[5][8] OPCs constantly survey their surroundings through actively extending and retracting processes that have been termed growth cone like processes.[9] Death or differentiation of an OPC is rapidly followed by migration or local proliferation of a neighboring cell to replace it.
In white matter, OPCs are found along unmyelinated axons
OPCs receive synaptic contacts onto their processes from both glutamatergic[14] and GABAergic neurons.[1][15] OPCs receive preferred somatic contacts from fast-spiking GABAergic neurons, while non-fast spiking interneurons have a preference for contacting the processes.[16] These inhibitory connections (in mice) occur mainly during a specific period in development, from postnatal day 8 till postnatal day 13.
Development
OPCs first appear during embryonic
In the
As development progresses, second and third waves of OPCs originate from Gsh2-expressing cells in the lateral and caudal ganglionic eminences and generate the majority of adult oligodendrocytes.[22] After the committed progenitor cells exit the germinal zones, they migrate and proliferate locally to eventually occupy the entire CNS parenchyma. OPCs are highly proliferative, migratory, and have bipolar morphology.[28]
OPCs continue to exist in both white and grey matter in the adult brain and maintain their population through self-renewal.
Fate
Typically beginning in
Differentiation of OPCs into oligodendrocytes involves massive reorganization of
Controversy
The possibility and in vivo relevance of OPC differentiation into astrocytes or neurons are highly debated.[1] Using Cre-Lox recombination-mediated genetic fate mapping, several labs have reported the fate of OPCs using different Cre driver and reporter mouse lines.[40] It is generally held that OPCs predominantly generate oligodendrocytes, and the rate at which they generate oligodendrocytes declines with age and is greater in white matter than in grey matter. Up to 30% of the oligodendrocytes that exist in the adult corpus callosum are generated de novo from OPCs over a period of 2 months. It is not known whether all OPCs eventually generate oligodendrocytes while self-renewing the population, or whether some remain as OPCs throughout the life of the animal and never differentiate into oligodendrocytes.[41]
OPCs may retain the ability to differentiate into astrocytes into adulthood.[42][43] Using NG2-Cre mice, it was shown that OPCs in the prenatal and perinatal grey matter of the ventral forebrain and spinal cord generate protoplasmic type II astrocytes in addition to oligodendrocytes. However, contrary to the prediction from optic nerve cultures, OPCs in white matter do not generate astrocytes. When the oligodendrocyte transcription factor Olig2 is deleted specifically in OPCs, there is a region- and age-dependent switch in the fate of OPCs from oligodendrocytes to astrocytes.[44]
Whereas some studies suggested that OPCs can generate
Function
As implied by their name, OPCs were long held to function purely as progenitors to oligodendrocytes. Their role as a progenitor cell type has since expanded to include both oligodendrocytes and some protoplasmic type II astrocytes in grey matter.[43] Later, additional functions were suggested.
Adult myelination
This section needs expansion. You can help by adding to it. (September 2021) |
Remyelination
Spontaneous myelin repair was first observed in cat models.[49] It was later discovered to occur in the human CNS as well, specifically in cases of multiple sclerosis (MS).[50] Spontaneous myelin repair does not result in morphologically normal oligodendrocytes and is associated with thinner myelin compared to axonal diameter than normal myelin.[51] Despite morphological abnormalities, however, remyelination does restore normal conduction.[52] In addition, spontaneous remyelination does not appear to be rare, at least in the case of MS. Studies of MS lesions reported the average extent of remyelination as high as 47%.[53] Comparative studies of cortical lesions reported a greater proportion of remyelination in the cortex as opposed to white matter lesions.[50]
OPCs retain the ability to proliferate in adulthood and comprise 70–90% of the proliferating cell population in the mature CNS.
Despite OPCs' potential to give rise to myelinating oligodendrocytes, complete myelin regeneration is rarely observed clinically or in chronic experimental models. Possible explanations for remyelination failure include depletion of OPCs over time, failure to recruit OPCs to the demyelinated lesion, and failure of recruited OPCs to differentiate into mature oligodendrocytes[58] (reviewed in[59][60][61]). In fresh MS lesions, clusters of HNK-1+ oligodendrocytes have been observed,[62] which suggests that under favorable conditions OPCs expand around demyelinated lesions and generate new oligodendrocytes. In chronic MS lesions where remyelination is incomplete, there is evidence that there are oligodendrocytes with processes extending toward demyelinated axons, but they do not seem to be able to generate new myelin.[63] The mechanisms that regulate differentiation of OPCs into myelinating oligodendrocytes are an active area of research.
Another unanswered question is whether the OPC pool eventually becomes depleted after it is used to generate remyelinating cells. Clonal analysis of isolated OPCs in the normal mouse forebrain suggests that in the adult, most clones originating from single OPCs consist of either a heterogeneous population containing both oligodendrocytes and OPCs or a homogeneous population consisting exclusively of OPCs, suggesting that OPCs in the adult CNS are able to self-renew and are not depleted under normal conditions.[64] However, it is not known whether this dynamic is altered in response to demyelinating lesions.
Neuron–OPC interactions
Node of Ranvier
OPCs extend their processes to the nodes of Ranvier[11] and together with astrocyte processes make up the nodal glial complex. Since the nodes of Ranvier contain a high density of voltage-dependent sodium channels and allow regenerative action potentials to be generated, it is speculated that this location allows OPCs to sense and possibly respond to neuronal activity.
Neuromodulation
OPCs synthesize the
Neuron–OPC synapse
OPCs express numerous
OPCs can undergo cell division while maintaining synaptic inputs from neurons.[70] These observations suggest that cells that receive neuronal synaptic inputs and those that differentiate into oligodendrocytes are not mutually exclusive cell populations but that the same population of OPCs can receive synaptic inputs and generate myelinating oligodendrocytes. However, OPCs appear to lose their ability to respond to synaptic inputs from neurons as they differentiate into mature oligodendrocytes.[71][72] The functional significance of the neuron-OPC synapses remains to be elucidated.
Immunomodulation
This section needs expansion. You can help by adding to it. (September 2021) |
OPCs may participate in both initiation and resolution of immune responses to disease or injury. They are highly responsive to injury, undergo a morphological activation similar to that of astrocytes and microglia, and may contribute to
Clinical significance
This article's tone or style may not reflect the encyclopedic tone used on Wikipedia. (September 2021) |
Transplantation of OPCs has been considered as a possible treatment for neurological diseases which cause demyelination. However, it is difficult to generate a suitable number of quality cells for clinical use. Finding a source for these cells remains impractical as of 2016. Should adult cells be used for transplantation, a brain biopsy would be required for each patient, adding to the risk of immune rejection. Embryonically derived stem cells have been demonstrated to carry out remyelination under laboratory conditions, but some religious groups are opposed to their use.[citation needed] Adult central nervous system stem cells have also been shown to generate myelinating oligodendrocytes, but are not readily accessible.[77]
Even if a viable source of OPCs were found, identifying and monitoring the outcome of remyelination remains difficult, though multimodal measures of conduction velocity and emerging magnetic resonance imaging techniques offer improved sensitivity versus other imaging methods.[78] In addition, the interaction between transplanted cells and immune cells and the effect of inflammatory immune cells on remyelination have yet to be fully characterized. If the failure of endogenous remyelination is due to an unfavorable differentiation environment, then this will have to be addressed prior to transplantation.[citation needed]
History
It had been known since the early 1900s that astrocytes, oligodendrocytes, and microglia make up the major glial cell populations in the mammalian CNS. The presence of another glial cell population had escaped recognition because of the lack of a suitable marker to identify them in tissue sections. The notion that there exists a population of glial progenitor cells in the developing and mature CNS began to be entertained in the late 1980s by several independent groups. In one series of studies on the development and origin of oligodendrocytes in the rodent CNS, a population of immature cells that appeared to be precursors to oligodendrocytes was identified by the expression of the GD3 ganglioside.[79]
In a separate series of studies, cells from
Independently, Stallcup and colleagues generated an antiserum that recognized a group of rat brain
See also
References
- ^ S2CID 15264205.
- PMID 21490970.
- PMID 22907787.
- ^ S2CID 25711458.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ PMID 23624515.
- ^ S2CID 21910392.
- S2CID 10924179.
- PMID 25926469.
- PMID 26388730.
- PMID 17293857.
- ^ S2CID 1688659.
- S2CID 22746971.
- PMID 25936593.
- ^ S2CID 4422069.
- S2CID 31596399.
- PMID 25902404.
- PMID 26584621.
- PMID 20532235.
- PMID 18627107.
- PMID 11567617.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 1865925.
- ^ PMID 16388308.
- PMID 10366594.
- S2CID 46878049.
- S2CID 16074660.
- S2CID 23154014.
- PMID 16870736.
- ^ PMID 14731493.
- PMID 7766839.
- PMID 10097168.
- PMID 18842903.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 24005306.
- PMID 18311136.
- PMID 24971048.
- PMID 34368163.
- PMID 22437915.
- PMID 21543611.
- PMID 22706957.
- PMID 20223198.
- PMID 21609823.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 21092857.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 4254924.
- ^ PMID 18045844.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 22627280.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 18849983.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 22699898.
- PMID 24799701.
- PMID 19058188.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 13688845.
- ^ PMID 5864468.
- S2CID 4246605.
- S2CID 2748982.
- S2CID 3158689.
- PMID 10704497.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 9247275.
- PMID 20569695.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 35526004.
- ^ PMID 11331369.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 19709750.
- S2CID 19055357.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 20142420.
- PMID 2811298.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 11796850.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 21266410.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 25966014.
- ^ S2CID 32067124.
- ^ PMID 25387269.
- S2CID 211214703.
- S2CID 8767161.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 25966213.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 20219994.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 20554883.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 33526585.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 33207109.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 30420755.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 31467299.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 25285506.
- S2CID 827480.
- S2CID 43450904.
- S2CID 4301091.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 1425339.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ PMID 6373111.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 943300.
- PMID 6263737.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 10330580.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link
External links
- Media related to Oligodendrocyte progenitor cell at Wikimedia Commons